Rxcurve
HCPCS J3250 · per 200 MG

Trimethobenzamide hcl inj

Products billed under this code include Tigan.

Payment limit per 200 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3250

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Tigan Henry Schein Inc. 00404-9964-02 1 $62.418
Tigan Endo USA, Inc. 42023-0119-25 25 $1,560.45
Tigan HF Acquisition Co. LLC, DBA HealthFirst 51662-1430-01 1 $62.418
Tigan HF Acquisition Co. LLC, DBA HealthFirst 51662-1430-03 25 $1,560.45

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $62.418 −$0.517 200 MG Trimethobenzamide hcl inj v1, posted September 17, 2026
3Q26 $62.935 +$5.715 200 MG Trimethobenzamide hcl inj v1, posted September 15, 2026
2Q26 $57.22 −$0.377 200 MG Trimethobenzamide hcl inj v1, posted September 15, 2026
1Q26 $57.597 +$0.091 200 MG Trimethobenzamide hcl inj v1, posted September 15, 2026
4Q25 $57.506 +$4.105 200 MG Trimethobenzamide hcl inj v1, posted September 8, 2026
3Q25 $53.401 +$3.363 200 MG Trimethobenzamide hcl inj v1, posted March 10, 2026
2Q25 $50.038 −$0.912 200 MG Trimethobenzamide hcl inj v1, posted March 10, 2026
1Q25 $50.95 −$0.279 200 MG Trimethobenzamide hcl inj v1, posted December 19, 2025
4Q24 $51.229 +$2.87 200 MG Trimethobenzamide hcl inj v1, posted June 11, 2025
3Q24 $48.359 −$0.21 200 MG Trimethobenzamide hcl inj v1, posted June 11, 2025
2Q24 $48.569 +$0.73 200 MG Trimethobenzamide hcl inj v1, posted March 11, 2025
1Q24 $47.839 +$2.894 200 MG Trimethobenzamide hcl inj v1, posted December 19, 2024
4Q23 $44.945 −$0.096 200 MG Trimethobenzamide hcl inj v1, posted October 10, 2024
3Q23 $45.041 +$0.10 200 MG Trimethobenzamide hcl inj v1, posted June 5, 2024
2Q23 $44.941 +$1.90 200 MG Trimethobenzamide hcl inj v1, posted February 23, 2024
1Q23 $43.041 +$0.16 200 MG Trimethobenzamide hcl inj v1, posted December 6, 2023
4Q22 $42.881 +$0.055 200 MG Trimethobenzamide hcl inj v1, posted June 22, 2023
3Q22 $42.826 −$0.264 200 MG Trimethobenzamide hcl inj v1, posted June 9, 2023
2Q22 $43.09 +$0.331 200 MG Trimethobenzamide hcl inj v1, posted December 14, 2022
1Q22 $42.759 +$1.856 200 MG Trimethobenzamide hcl inj v1, posted June 8, 2022
4Q21 $40.903 +$0.196 200 MG Trimethobenzamide hcl inj v1, posted June 2, 2022
3Q21 $40.707 +$0.10 200 MG Trimethobenzamide hcl inj v1, posted June 2, 2022
2Q21 $40.607 +$0.074 200 MG Trimethobenzamide hcl inj v1, posted March 1, 2022
1Q21 $40.533 – 200 MG Trimethobenzamide hcl inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files